Surgical-Wound Surveillance

restriction endonucleases with infrequent recognition sites. / Clin Microbiol 1990;28:2059-2063. 26. Miele A, Bandera M, Goldstein BR Use of primers selective for vancomycin resistance genes to determine van genotype in enterococci and to study gene organization in vanA isolates. Antimicrob Agents Chemother 1995;39:1772-1778. 27. Humar A, Dedier I, Campbell I, Brunton J, Willey B, Low D, et al. Clinical and microbiological analysis of a vancomycin-resistant Enterococcus outbreak in a dialysis population. Presented at the 36th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy; September 1996; New Orleans, LA Abstract J3. 28. Berntson A Green K, Willey B, Fleming CA, Blacklock A, Richardson H, et al. Emergence of vancomycin-resistant enterococci in Ontario. Presented at the 37th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy; September 28-October 1, 1997; Toronto, Ontario, Canada. Abstract C-154. 29. Willey BM, Blacklock A Ontario VRE Surveillance Study, McGeer A, Low DE. Molecular epidemiology of the emergence of vancomycinresistant enterococci in Ontario, Canada. Presented at the 36th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy; September 15-18,1996; New Orleans, LA Abstract C16. 30. Boyce JM, Opal SM, Chow JW, et al. Outbreak of multidrug resistant Enterococcus faecium with transferable vanB class vancomycin resistance./ Clin Microbiol 1994;22:1148-1153. 31. Moreno F, Grota P, Crisp C, Magnon K, Melcher GP, Jorgensen JH, et al. Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas. Clin Infect Dis 1995;21:1234-1237. 32. Pegues DA Pegues C, Hibberd B, Ford D, Hooper D. Emergence and dissemination of a highly-vancomycin resistant vanA strain of Enterococcus faecium at a large teaching hospital. / Clin Microbiol 1997;35:1565-1570. 33. New York State Department of Health. Supplemental Infection Control Guidelines for the Care of Patients Colonized or Infected With VancomycinResistant Enterococci in Hospitals, Long Term Care Facilities, and Home Health Care. Health Facilities Series 95-14. State of New York Department of Health memorandum. Albany, NY: NYS Dept of Health; 1995. 34. Chia JKS, Nakata MM, Parks SS, Lewis RP, McKee B. Use of bacitracin therapy for infection due to vancomycin-resistant Enterococcus faecium. Clin Infect Dis 1995;21:1520. 35. McGeer A, Cann D, Mustachi B, Willey B, Wigston C, Low DE. Evaluation of oral bacitracin therapy for the eradication of colonization of resistant enterococci. Presented at the 35fh Interscience Conference on Antimicrobial Agents and Chemotherapy; September 1995; San Francisco, CA Abstract J142. 36. O'Donovan CA Fan-Havard P, Tecson-Tumang FT, Smith SM, Eng RHK. Enteric eradication of vancomycin-resistant Enterococcus faecium with oral bacitracin. Diagn Microbiol Infect Dis 1994;18:105-109. 37. Montecalvo MA, deLancastre H, Carraher M, Gedris C, Chung M, Van Horn K, et al. Natural history of colonization with vancomycinresistant Enterococcus faecium. Infect Control Hosp Epidemiol 1995;16:680-685. 38. Green M, Barbadora H, Michaels M. Recovery of vancomycin-resistant gram positive cocci from pediatric liver transplant patients. / Clin Microbiol 1991;29:2503-2506.